NuCana's Acelarin Achieves High Disease Control Rate in Patients with Advanced Cancer
Released: Monday 2nd June 2014
The voice of Scotland's life sciences industries
- Gordon Pirie joins AM Sci Tech as Asset Manager at Aberdeen Energy and Innovation Parks
- BioAscent awarded prestigious Knowledge Transfer Partnership
- Merck announces investment of over £4 million in its facility in Livingston
- NuCana Presents Encouraging Data at ESMO Congress 2024
- Medannex awarded grant to accelerate new treatment for bone cancer in children
- All Members' News
© Scottish Lifesciences Association 2024
Scottish Lifesciences Association, 44 Charlotte Square, Edinburgh, EH2 4HQ, Scotland
Registered in Scotland - SC390602
Tel: +44 (0) 7753 312 263
